Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière’s Disease: Case Report and Review of the Literature

<table>Monitoring of dynamic changes of hVOR with the vHIT in intratympanic gentamicin treatment. (a) Before therapy, (b)–(e) 1–4 weeks after therapy. Grey: hVOR: eye acceleration, black: head acceleration. Time-dependent reduction of hVOR gain and appearance of overt and covert refixation saccades.</table>

Case Reports in Otolaryngology

fig1

Figure 1

Figure 1: Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière’s Disease: Case Report and Review of the Literature 

Figure 1 | Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière’s Disease: Case Report and Review of the Literature 